- The Wall Street Journal•yesterday
Laboratory Corp. said it posted revenue and profit growth in its latest quarter as acquisitions bolstered results. It also said it was buying Sequenom in a deal worth about $302 million.
Laboratory Corporation of America Holdings said it would buy Sequenom Inc, a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt. The $2.40 per share cash offer, which has a total equity value of $302 million, represents a 182 percent premium to Sequenom's Tuesday close. Sequenom's shares rose 177 percent to $2.36 in premarket trading on Wednesday.
|Bid||2.36 x 59300|
|Ask||2.37 x 208100|
|52wk Range||0.82 - 2.86|
|Day's Range||2.35 - 2.37|
|Avg Vol (3m)||1,611,388|
As of 1:37 PM EDT. NasdaqGS Real Time Price. Market open.